节点文献

原发性肝癌患者微波消融治疗后外周血T淋巴细胞亚群的变化

Changes in peripheral T lymphocyte subsets in patients underwent microwave ablation for primary liver cancer

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 阚晓潘家超荆燕都晓伟史兆章韩绍磊张海涛郑昭敏

【Author】 Kan Xiao;Pan Jiachao;Jing Yan;Infectious Disease Hospital,Shandong University;

【机构】 山东大学附属济南市传染病医院介入科山东大学医学院山东大学附属济南市传染病医院检验室山东省潍坊市昌乐县人民医院感染病科

【摘要】 目的观察原发性肝癌患者微波消融治疗前后外周血T淋巴细胞亚群的变化。方法 152例原发性肝癌患者在微波消融治疗前1d、治疗后1 w和4 w,以流式细胞术检测患者外周血CD4+和CD8+淋巴细胞数量,采用全自动生化免疫分析仪检测甲胎蛋白水平。术后1 m进行肝脏CT增强扫描观察。结果在微波消融治疗后1 w和4 w,患者外周血CD4+T淋巴细胞上升至(26.5±3.8)%和(32.3±5.1)%,CD4+/CD8+比值上升至(1.12±0.43)和(1.51±0.40),而CD8+T淋巴细胞下降至(47.2±7.7)%和(28.1±7.3)%,与治疗前1d时基线水平[CD4+、CD8+和CD4+/CD8+分别为(21.4±4.1)%、(58.6±7.8)%和(0.98±0.45)]比,变化有统计学意义(P均<0.05);甲胎蛋白水平由基线水平[(1109±727)ng/ml]下降,术后1w和4w分别为(890±681)ng/ml和(215±18)ng/ml(P<0.01);微波消融后1m行增强CT检查,示病灶完全灭活率为97.4%(148/152)。结论微波消融治疗使原发性肝癌患者外周血T淋巴细胞亚群向CD4+T淋巴细胞优势转变,可能对治疗效果的取得发挥了作用。

【Abstract】 Objective To investigate the changes of peripheral T lymphocyte subsets in patients with primary liver cancer(PLC)underwent microwave ablation. Method 152 patients with PLC were recruited and received microwave ablation treatment. One day before,and 1 week and 4 weeks after the treatment,the distributions of peripheral T lymphocyte subsets were determined by flow cytometry,and serum levels of alpha fetoprotein were measured by a automatic biochemical immune analyzer. Contrast-enhanced CT scans were performed in all patients one month after the treatment. Results The percentages of CD4+ or CD8+T lymphocytes and the ratio of CD4+/CD8+in this series one day before the treatment were(21.4±4.1)%,(58.6±7.8)% and(0.98±0.45),respectively,while the percentages of CD4+T lymphocytes increased to(26.5±3.8)% and(32.3±5.1)%,and the CD4+/CD8+ratio increased to(1.12±0.43)and(1.51±0.40),but CD8+T lymphocytes decreased to(47.2±7.7)% and(28.1±7.3)%, respectively(P<0.05)one week and 4 weeks after microwave ablation; serum alpha fetoprotein levels were significantly decreased from the baseline [(1109±727) ng/ml] to(890±681) ng/ml 1 week or(215±18) ng/ml 4 weeks after ablation(P<0.01);contrast-enhanced CT scans revealed a complete ablation rate of 97.37%(148/152) for tumors one month after therapy. Conclusions Microwave ablation for PLC shifts the distribution of peripheral blood T lymphocyte subsets toward a CD4+cells-favorite status,which might play a role in improving the efficacy of the therapy.

  • 【文献出处】 实用肝脏病杂志 ,Journal of Practical Hepatology , 编辑部邮箱 ,2014年01期
  • 【分类号】R735.7
  • 【被引频次】13
  • 【下载频次】163
节点文献中: 

本文链接的文献网络图示:

本文的引文网络